The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose …

P Xu, RSM Wong, X Yan - Journal of Pharmaceutical Sciences, 2024 - Elsevier
Erythropoiesis-stimulating agents (ESAs) have been a common treatment for anemia
associated with chronic kidney disease (CKD), while 10–20% of patients continue to suffer …
被引用次数：1 相关文章

The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose …

P Xu, RSM Wong, X Yan - Journal of pharmaceutical …, 2024 - pubmed.ncbi.nlm.nih.gov
Erythropoiesis-stimulating agents (ESAs) have been a common treatment for anemia
associated with chronic kidney disease (CKD), while 10-20% of patients continue to suffer …

The Influence of Precursor Depletion and dose Regimens on Resistance to Erythropoiesis-Stimulating Agents: Insights from Simulations with Instantaneous Dose …

P Xu, RSM Wong, X Yan - Journal of Pharmaceutical Sciences, 2024 - jpharmsci.org
Erythropoiesis-stimulating agents (ESAs) have been a common treatment for anemia
associated with chronic kidney disease (CKD), while 10–20% of patients continue to suffer …

The influence of precursor depletion and dose regimens on resistance to erythropoiesis-stimulating agents: insights from simulations with instantaneous dose …

X Peng, RSM Wong, X Yan - Journal of Pharmaceutical Sciences, 2023 - europepmc.org
Erythropoiesis-stimulating agents (ESAs) have been a common treatment for anemia
associated with chronic kidney disease (CKD), while 10-20% of patients continue to suffer …